Iniston Mucosidad Y Congestión

Pseudoephedrine Hydrochloride, the active ingredient in Iniston Mucosidad Y Congestión, is a decongestant presented as an oral dosage form for oral use. It relieves nasal congestion and reduces mucus thickness, helping adults and adolescents manage common cold symptoms.\n\nGNH India supplies Iniston Mucosidad Y Congestión as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Iniston Mucosidad Y Congestión combines a decongestant and an expectorant to address upper‑respiratory tract conditions.\n\n- Nasal congestion: reduces swelling of nasal mucosa to improve airflow.\n- Mucus buildup: thins respiratory secretions, facilitating clearance.\n- Common cold symptoms: alleviates blockage and productive cough associated with viral upper‑respiratory infections.

Adverse reactions may occur with oral decongestant‑expectorant combinations.\n\nCommon Side Effects:\n- Insomnia or difficulty sleeping\n- Nervousness or restlessness\n- Headache\n- Dry mouth or throat\n- Tachycardia or palpitations\n\nSerious or Rare Side Effects:\n- Elevated blood pressure or hypertension\n- Cardiac arrhythmias\n- Severe allergic reactions (rash, swelling, anaphylaxis)\n- Seizures in predisposed individuals\n- Hallucinations or severe agitation

When using Iniston Mucosidad Y Congestión, consider the following safety measures.\n\n- Assess cardiovascular status: avoid in uncontrolled hypertension.\n- Do not combine with monoamine oxidase inhibitors (MAOIs) or within 14 days of MAOI therapy.\n- Use caution in patients with diabetes, as it may affect blood glucose control.\n- Pregnant or breastfeeding individuals should consult a healthcare professional before use.\n- Store below 25°C: keep in the original pack, protect from moisture.

Pseudoephedrine and guaifenesin may interact with several drug classes.\n\nMajor Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.\n- Certain antihypertensive agents (e.g., β‑blockers): may reduce efficacy of blood‑pressure control.\n\nModerate Interactions (Monitor Closely):\n- Other sympathomimetic decongestants: additive stimulant effects.\n- Diuretics: may enhance pseudoephedrine‑induced hypokalemia.\n- Alcohol or CNS depressants: may increase dizziness or drowsiness.